Tag : genomic testing

DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, has appointed two new members...

Renowned leaders Alessandra Cesano, Julie Cherrington, and Mike Varney to serve in scientific and strategic advisor roles GV20 Therapeutics, a biopharmaceutical company using cutting-edge genomics...

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of Jeff Eidel as Chief Commercial Officer, effective August 16, 2022. In this role,...

Integration of discrete genetic results improves patient outcomes with targeted treatments Frederick Health (Frederick, MD) is one of the first organizations to automatically incorporate discrete genetic...

With $57M in initial financing, Cartography is creating immunotherapies that are more precise and more effective Cartography is combining cutting-edge computational and experimental techniques to...

Expanded Access for 125,000 American Lives for Highly Accurate, Novel Blood Tests Prevencio, Inc. today announces that Atlas Genomics, Prevencio’s performing laboratory for its Artificial Intelligence (AI)-driven...

Tectonic Therapeutic, Inc. a pre-clinical stage biotechnology company transforming the discovery of novel GPCR-targeted therapies (G-Protein Coupled Receptors), today announced the promotion of Senior Vice...

KromaTiD, a single-cell analysis company focused on the research, development, and commercialization of technology solutions for the cell and gene therapy market, announces the launch...

—   COO Kenneth D. Knight named CEO succeeding Sean George; Dr. George to continue as member of Board of Directors — —   Co-Founder and former CEO Randy Scott returns as chairman — —   Current...

Nabsys, the pioneer in electronic whole-genome mapping, announced the appointment of Kevin DeGeeter as Chief Financial Officer. “I am excited to welcome Kevin to the executive team,”...